CHANGES IN ULTRASONOGRAPHIC VASCULARITY UPON INITIATION OF ADALIMUMAB COMBINATION THERAPY IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE

被引：0
|
作者：
Kaeley, G. S. [1 ]
Nishio, M. J. [2 ]
Goyal, J. R. [3 ]
MacCarter, D. K. [4 ]
Wells, A. F. [5 ]
Cardoso, A. [6 ]
Chen, S. [7 ]
Kalabic, J. [8 ]
Kupper, H. [8 ]
机构：
[1] Univ Florida, Coll Med, Jacksonville, FL USA
[2] Diablo Clin Res, Walnut Creek, CA USA
[3] Raritan Bay Med Ctr, Perth Amboy, NJ USA
[4] DK MacCarter Coeur dAlene Arthrit Clin, Coeur Dalene, ID USA
[5] Rheumatol & Immunotherapy Ctr, Franklin, TN USA
[6] AbbVie Inc, Lisbon, Portugal
[7] AbbVie Inc, N Chicago, IL USA
[8] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.1389
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0238
引用
收藏
页码：469 / 469
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Japanese Rheumatoid Arthritis Patients with An Inadequate Response to Methotrexate
    Yamamoto, Kazuhiko
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Tanaka, Yoshiya
    Eguchi, Katsumi
    Watanabe, Akira
    Origasa, Hideki
    Shoji, Toshiharu
    Sakamaki, Yoshiharu
    Miyasaka, Nobuyuki
    Koike, Takao
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S474 - S475
  • [42] Efficacy Of Adalimumab Plus Methotrexate Therapy In Rheumatoid Arthritis Non-Responders Receiving Methotrexate Monotherapy Or Adalimumab Combination Therapy: Results From The Optima Trial
    Smolen, Josef S.
    van Vollenhoven, Ronald F.
    Fleischmann, Roy
    Emery, Paul
    Florentinus, Stefan
    Rathmann, Suchitrita S.
    Cardoso, Anabela
    Kupper, Hartmut
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S999 - S1000
  • [43] EFFICACY OF ADALIMUMAB PLUS METHOTREXATE THERAPY IN RHEUMATOID ARTHRITIS NON-RESPONDERS RECEIVING METHOTREXATE MONOTHERAPY OR ADALIMUMAB COMBINATION THERAPY: RESULTS FROM THE OPTIMA TRIAL
    Smolen, Josef S.
    van Vollenhoven, Ronald F.
    Fleischmann, Roy
    Emery, Paul
    Florentinus, Stefan
    Rathmann, Suchitrita S.
    Cardoso, Anabela
    Kupper, Hartmut
    Kavanaugh, Arthur
    RHEUMATOLOGY, 2014, 53 : 89 - 89
  • [44] EFFECTIVENESS OF ADALIMUMAB COMBINATION THERAPY WITH METHOTREXATE AND NON-METHOTREXATE CSDMARDS: RESULTS FROM THE CORRONA RHEUMATOID ARTHRITIS REGISTRY
    Pappas, D.
    Griffith, J.
    Schlacher, C. A.
    Suboticki, J. L.
    Harrison, R. W.
    Shan, Y.
    Karki, C.
    Kremer, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 552 - 553
  • [45] Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients
    Stephanie F. Ling
    Nisha Nair
    Suzanne M. M. Verstappen
    Anne Barton
    Hans-Dieter Zucht
    Petra Budde
    Peter Schulz-Knappe
    Darren Plant
    The Pharmacogenomics Journal, 2020, 20 : 516 - 523
  • [46] Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab
    Ornetti, P
    Solau, E
    Gaudin, P
    Sibilia, J
    Berthelot, JM
    Puechal, X
    Tavernier, C
    Maillefert, JF
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (09) : 1379 - 1380
  • [47] Cost-effectiveness of treatment strategies for rheumatoid arthritis patients with inadequate response to methotrexate
    Patel, VD
    Hay, J
    VALUE IN HEALTH, 2004, 7 (03) : 241 - 241
  • [48] Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate
    Buch, Maya H.
    Walker, David
    Edwards, Christopher J.
    Barry, Jane
    Akroyd, Laura
    Omoruyi, Edmund V. Ekoka
    Taylor, Peter C.
    RHEUMATOLOGY, 2024,
  • [49] Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients
    Ling, Stephanie F.
    Nair, Nisha
    Verstappen, Suzanne M. M.
    Barton, Anne
    Zucht, Hans-Dieter
    Budde, Petra
    Schulz-Knappe, Peter
    Plant, Darren
    PHARMACOGENOMICS JOURNAL, 2020, 20 (03): : 516 - 523
  • [50] Treating Rheumatoid Arthritis to Target: Outcomes and Predictors in Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate, Methotrexate Alone, or Methotrexate Plus Subsequent Adalimumab
    Smolen, Josef
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Wolfe, Benjamin
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S665 - S665
12345